EUVIMEDEUVIMED entdecken
Crossref

Combatting Silicosis Fibrosis: Methyl Gallate Suppresses Pathogenic Fibroblasts Through hnRNPA2 / B1 ‐ MDM4 ‐ P53 Network Disruption

Y Wei, Y J Wu, W R He, P Zhao iD, Q Zhang, J S Li

The FASEB Journal · 2026

DOI: 10.1096/fj.202502303rr ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, 2026. Verfasst von Y Wei und 5 weiteren Autor:innen. Beteiligte Einrichtung: Henan Key Laboratory of Chinese Medicine for Respiratory Disease, Henan University of Chinese Medicine, Zhengzhou, Henan, China. Hauptthemen laut MEDLINE: Tumor Suppressor Protein p53, Fibroblasts, Heterogeneous-Nuclear Ribonucleoprotein Group A-B, Proto-Oncogene Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Key Scientific Research Projects of Colleges and Universities of Henan Province, Training Program for Young Core Faculty in Undergraduate Universities in Henan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Silicosis, an occupational pulmonary fibrosis caused by silica dust exposure, lacks effective treatments. This study investigates the therapeutic potential and mechanism of methyl gallate (MG), a natural polyphenol, in silicosis fibrosis. A silica‐induced silicosis mouse model and TGF‐β1‐stimulated human lung fibroblasts were employed. MG administration significantly ameliorated lung fibrosis in mice, reducing collagen deposition, α‐SMA, fibronectin, and TGF‐β1 levels. Transcriptomic analysis revealed that MG inhibited fibroblast activation by suppressing cell cycle progression via CDK6‐mediated G0/G1 arrest. Mechanistically, MG downregulated MDM4 protein levels, disrupted MDM4‐P53 interaction, and activated the P53‐P21 pathway, promoting fibroblast apoptosis and cell cycle arrest. Further, Drug Affinity Responsive Target Stability (DARTS) and Cellular Thermal Shift Assay (CETSA) identified hnRNPA2/B1 as MG's direct target. MG inhibited hnRNPA2/B1‐mediated MDM4 mRNA translation, thereby reducing MDM4 protein synthesis. Overexpression of MDM4 or knockdown of hnRNPA2/B1 reversed MG's anti‐fibrotic effects. These findings highlight MG's novel role in alleviating silicosis fibrosis by targeting the hnRNPA2/B1‐MDM4‐P53 axis, offering a promising therapeutic strategy for silicosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor Suppressor Protein p53FibroblastsHeterogeneous-Nuclear Ribonucleoprotein Group A-BProto-Oncogene ProteinsSilicosisPulmonary FibrosisCell Cycle ProteinsAnimalsMiceHumansMaleMice, Inbred C57BLSignal TransductionApoptosisFibrosis

Stichwörter der Autor:innen

MDM4fibroblastshnRNPA2/B1methyl gallatesilicosis

Substanzen

Tumor Suppressor Protein p53Heterogeneous-Nuclear Ribonucleoprotein Group A-BProto-Oncogene ProteinshnRNP A2Mdm4 protein, mouseCell Cycle Proteins

Autor:innen und Institutionen

  • Henan Key Laboratory of Chinese Medicine for Respiratory Disease, Henan University of Chinese Medicine, Zhengzhou, Henan, China.
  • Collaborative Innovation Center for Chinese Medicine and Respiratory Diseases Co-Constructed by Henan Province & Education Ministry of P.R. China, Zhengzhou, Henan, China.
  • Academy of Chinese Medical Sciences, Henan University of Chinese Medicine, Zhengzhou, China.
  • Department of Respiratory Diseases, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, China.

ORCID-Profile: P Zhao

Förderung

  • National Natural Science Foundation of China
  • Key Scientific Research Projects of Colleges and Universities of Henan Province
  • Training Program for Young Core Faculty in Undergraduate Universities in Henan Province

Zitieren

APA

Wei, Y., Wu, Y. J., He, W. R., Zhao, P., Zhang, Q., & Li, J. S. (2026). Combatting Silicosis Fibrosis: Methyl Gallate Suppresses Pathogenic Fibroblasts Through hnRNPA2 / B1 ‐ MDM4 ‐ P53 Network Disruption. The FASEB Journal. https://doi.org/10.1096/fj.202502303rr

Vancouver

Wei Y, Wu YJ, He WR, Zhao P, Zhang Q, Li JS. Combatting Silicosis Fibrosis: Methyl Gallate Suppresses Pathogenic Fibroblasts Through hnRNPA2 / B1 ‐ MDM4 ‐ P53 Network Disruption. The FASEB Journal. 2026. doi:10.1096/fj.202502303rr

BibTeX
@article{Wei2026,
  author = {Wei, Y and Wu, Y J and He, W R and Zhao, P and Zhang, Q and Li, J S},
  title = {Combatting Silicosis Fibrosis: Methyl Gallate Suppresses Pathogenic Fibroblasts Through hnRNPA2 / B1 ‐ MDM4 ‐ P53 Network Disruption},
  journal = {The FASEB Journal},
  year = {2026},
  doi = {10.1096/fj.202502303rr}
}
Kostenlos starten →